サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1726216

ヒト乳頭腫ウイルス検査市場規模、シェア、動向分析レポート：用途別、製品別、技術別、最終用途別、地域別、セグメント別予測、2025年～2030年

Human Papilloma Virus Testing Market Size, Share, & Trends Analysis Report By Application (Cervical Cancer Screening, Vaginal Cancer Screening), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 110 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
ヒト乳頭腫ウイルス検査市場規模、シェア、動向分析レポート：用途別、製品別、技術別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年04月11日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向

ヒト乳頭腫ウイルス（HPV）検査の世界市場規模は、2024年に17億6,000万米ドルと評価され、子宮頸がんや咽頭がんなどのHPV関連がんに対する意識の高まりに起因して、2025～2030年にかけてCAGR 13.6％で成長すると予測されています。

教育的な取り組みや公衆衛生キャンペーンにより、定期的に検査を受けることが奨励され、検診率の上昇につながっています。

家庭用検査キットの採用が市場拡大をさらに後押ししています。これらのキットは、個人がHPVを検査するのに便利で、個人的で、利用しやすい方法を提供し、利用者がより積極的に健康を管理できるようにします。意識の高まりと家庭での検査が可能になったことが、市場の需要を大幅に押し上げています。

予防ヘルスケアに対する需要の高まりは、HPV検査産業の成長を促進すると予測され、HPV関連がんを回避するために早期発見を求める個人が増加しています。このような積極的な健康対策へのシフトは、特に30歳以上の女性に対して、定期的なHPVスクリーニング検査を奨励しています。PCR法や次世代シークエンシング法を含む検査法の技術的進歩は、HPV検査の精度と効率をさらに高めています。このような技術革新は、検査をより利用しやすく、信頼性が高く、費用対効果が高いものにするため、患者の全体的な体験を向上させ、HPV検査ソリューションの広範な採用を促すことによって、市場拡大を後押ししています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヒトパピローマウイルス（HPV）検査市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ヒトパピローマウイルス（HPV）検査市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 ヒトパピローマウイルス（HPV）検査市場：用途別、推定・動向分析

  • 用途セグメントダッシュボード
  • ヒトパピローマウイルス（HPV）検査市場：用途変動分析
  • 世界のヒトパピローマウイルス（HPV）検査市場規模と動向分析（用途別、2018～2030年）
  • 子宮頸がん検診
  • 膣がん検診

第5章 ヒトパピローマウイルス（HPV）検査市場：製品別、推定・動向分析

  • 製品セグメントダッシュボード
  • ヒトパピローマウイルス（HPV）検査市場：製品変動分析
  • 世界のヒトパピローマウイルス（HPV）検査市場規模と動向分析（製品別、2018～2030年）
  • 機器
  • 消耗品
  • サービス

第6章 ヒトパピローマウイルス（HPV）検査市場：技術別、推定・動向分析

  • 技術セグメントダッシュボード
  • ヒトパピローマウイルス（HPV）検査市場：技術変動分析
  • 世界のヒトパピローマウイルス（HPV）検査市場規模と動向分析（技術別、2018～2030年）
  • PCR
  • 免疫診断
  • その他

第7章 ヒトパピローマウイルス（HPV）検査市場：最終用途別、推定・動向分析

  • 最終用途セグメントダッシュボード
  • ヒトパピローマウイルス（HPV）検査市場：最終用途変動分析
  • 世界のヒトパピローマウイルス（HPV）検査市場規模と動向分析（最終用途別、2018～2030年）
  • 病院とクリニック
  • ラボ
  • その他

第8章 ヒトパピローマウイルス（HPV）検査市場：地域別、推定・動向分析

  • 地域別市場ダッシュボード
  • 地域別市場シェア分析、2024年と2030年
  • 地域別ヒトパピローマウイルス（HPV）検査市場：主要ポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業ヒートマップ分析、2024年
  • 企業プロファイル
    • Abbott
    • Biomedical Diagnostics
    • bioMerieux
    • CanAg Diagnostics（Beijing）Co., Ltd.
    • Cemines
    • Bio-Rad Laboratories, Inc.
    • Epigenomics AG
    • Fujirebio
    • Guided Therapeutics, Inc.
    • Oncolab
    • Hologic, Inc.
    • Qiagen
    • Radiant Pharmaceuticals Limited
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Human Papilloma Virus (HPV) Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 5. Global Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 6. Global Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7. Global Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8. North America Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 10. North America Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 11. North America Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12. North America Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 14. U.S. Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. U.S. Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16. U.S. Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Canada Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 18. Canada Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 19. Canada Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20. Canada Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21. Mexico Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 22. Mexico Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23. Mexico Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 24. Mexico Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25. Europe Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 27. Europe Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. Europe Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29. Europe Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. Germany Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 31. Germany Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. Germany Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33. Germany Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34. U.K. Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 35. U.K. Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 36. U.K. Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37. U.K. Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38. France Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 39. France Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 40. France Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41. France Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Italy Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 43. Italy Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 44. Italy Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 45. Italy Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46. Spain Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 47. Spain Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 48. Spain Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49. Spain Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50. Denmark Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 51. Denmark Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 52. Denmark Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53. Denmark Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Sweden Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 55. Sweden Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 56. Sweden Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57. Sweden Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Norway Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 59. Norway Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 60. Norway Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 61. Norway Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67. Japan Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 68. Japan Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 69. Japan Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70. Japan Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71. China Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 72. China Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 73. China Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74. China Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75. India Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 76. India Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77. India Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78. India Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79. South Korea Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 80. South Korea Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 81. South Korea Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82. South Korea Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83. Australia Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 84. Australia Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 85. Australia Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86. Australia Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Thailand Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 88. Thailand Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 89. Thailand Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90. Thailand Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91. Latin America Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 93. Latin America Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 94. Latin America Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95. Latin America Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96. Brazil Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 97. Brazil Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 98. Brazil Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99. Brazil Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100. Argentina Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 101. Argentina Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 102. Argentina Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103. Argentina Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 109. South Africa Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 110. South Africa Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 111. South Africa Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 112. South Africa Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 117. UAE Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 118. UAE Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 119. UAE Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 120. UAE Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Human Papilloma Virus (HPV) Testing Market: Market Outlook
  • Fig. 10 Human Papilloma Virus (HPV) Testing Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Human Papilloma Virus (HPV) Testing Market Driver Impact
  • Fig. 16 Human Papilloma Virus (HPV) Testing Market Restraint Impact
  • Fig. 17 Human Papilloma Virus (HPV) Testing Market Strategic Initiatives Analysis
  • Fig. 18 Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
  • Fig. 19 Human Papilloma Virus (HPV) Testing Market: Application Outlook and Key Takeaways
  • Fig. 20 Cervical Cancer Screening Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Vaginal Cancer Screening Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
  • Fig. 23 Human Papilloma Virus (HPV) Testing Market: Product Outlook and Key Takeaways
  • Fig. 24 Instruments Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Consumables Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Services Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
  • Fig. 28 Human Papilloma Virus (HPV) Testing Market: Technology Outlook and Key Takeaways
  • Fig. 29 PCR Market, 2018 - 2030 (USD Million)
  • Fig. 30 Immunodiagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 31 Others Market, 2018 - 2030 (USD Million)
  • Fig. 32 Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
  • Fig. 33 Human Papilloma Virus (HPV) Testing Market: End Use Outlook and Key Takeaways
  • Fig. 34 Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 35 Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 36 Others Market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Human Papilloma Virus (HPV) Testing Market: Regional Movement Analysis
  • Fig. 38 Global Human Papilloma Virus (HPV) Testing Market: Regional Outlook and Key Takeaways
  • Fig. 39 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 U.K. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Kuwait Market Estimates and Forecasts, 2018 - 2030
目次
Product Code: GVR-4-68040-549-5

Market Size & Trends:

The global human papilloma virus testing market size was valued at USD 1.76 billion in 2024 and is expected to grow at a CAGR of 13.6% from 2025 to 2030, attributed to increasing awareness of HPV-related cancers, such as cervical and throat cancers. Educational initiatives and public health campaigns encourage people to get tested regularly, leading to higher screening rates.

The adoption of at-home testing kits is further driving market expansion. These kits provide a convenient, private, and accessible method for individuals to test for HPV, empowering users to manage their health more proactively. The combination of heightened awareness and the availability of at-home testing is significantly boosting market demand.

Rising demand for preventive healthcare is projected to fuel the growth of the HPV testing industry, with more individuals seeking early detection to avoid HPV-related cancers. This shift toward proactive health measures encourages routine HPV screenings, especially for women over 30. Technological advancements in testing methods, including PCR-based and next-generation sequencing, are further enhancing the accuracy and efficiency of HPV tests. These innovations make testing more accessible, reliable, and cost-effective, thus driving market expansion by improving the overall patient experience and encouraging broader adoption of HPV testing solutions.

Global Human Papilloma Virus Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global human papilloma virus (HPV) testing market report on the basis of application, product, technology, end use, and region:

  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Cervical Cancer Screening
  • Vaginal Cancer Screening
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Instruments
  • Consumables
  • Services
  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • PCR
  • Immunodiagnostics
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Product
    • 1.2.3. Technology
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Outlook
    • 2.2.2. Product Outlook
    • 2.2.3. Technology Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Scenario

Chapter 3. Human Papilloma Virus (HPV) Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Human Papilloma Virus (HPV) Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Human Papilloma Virus (HPV) Testing Market: Application Estimates & Trend Analysis

  • 4.1. Application Segment Dashboard
  • 4.2. Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
  • 4.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
  • 4.4. Cervical Cancer Screening
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Vaginal Cancer Screening
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Human Papilloma Virus (HPV) Testing Market: Product Estimates & Trend Analysis

  • 5.1. Product Segment Dashboard
  • 5.2. Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
  • 5.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Consumables
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Services
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Papilloma Virus (HPV) Testing Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Segment Dashboard
  • 6.2. Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
  • 6.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Technology, 2018 to 2030 (USD Million)
  • 6.4. PCR
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Immunodiagnostics
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Human Papilloma Virus (HPV) Testing Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
  • 7.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Laboratories
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Human Papilloma Virus (HPV) Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. Human Papilloma Virus (HPV) Testing Market by Region: Key Takeaways
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key Country Dynamics
      • 8.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.1.3. Competitive Scenario
      • 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Germany
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.1.3. Competitive Scenario
      • 8.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.2. U.K.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Denmark
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Norway
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.8.3. Competitive Scenario
      • 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.1.3. Competitive Scenario
      • 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.4. South Korea
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.2.3. Competitive Scenario
      • 8.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.3.3. Competitive Scenario
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.4.3. Competitive Scenario
      • 8.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.5.3. Competitive Scenario
      • 8.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/ Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key Company Heat Map Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Abbott
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Biomedical Diagnostics
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. bioMerieux
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. CanAg Diagnostics (Beijing) Co., Ltd.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Cemines
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Bio-Rad Laboratories, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Epigenomics AG
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Fujirebio
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Guided Therapeutics, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Oncolab
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Hologic, Inc.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Qiagen
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. Radiant Pharmaceuticals Limited
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. F. Hoffmann-La Roche Ltd
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Siemens Healthineers AG
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives